As of Beijing time The data is from a third-party organization and is only for reference.
For actual information, please refer to：www.eastmoney.com
Address: 20 Maguire Road, Suite 103, Lexington, MA 02421(America)
Tel: +1(626)986-9880
Address: Allia Future Business Centre Kings Hedges Road Cambridge CB4 2HY, UK
Tel: 0044 7790 816 954
Email: marketing@medicilon.com
Address: No.585 Chuanda Road, Pudong New Area, Shanghai (Headquarters)
Postcode: 201299
Tel: +86 (21) 5859-1500 (main line)
Fax: +86 (21) 5859-6369
© 2023 Shanghai Medicilon Inc. All rights reserved Shanghai ICP No.10216606-3
Shanghai Public Network Security File No. 31011502018888 | Website Map
Business Inquiry
Global：
Email:marketing@medicilon.com
+1(626)986-9880(U.S.)
0044 7790 816 954 (Europe)
China：
Email: marketing@medicilon.com.cn
Tel: +86 (21) 5859-1500
On May 22, 2020, Kintor Pharmaceutical Limited (stock code: 9939. HK) was officially listed on the Hong Kong Stock Exchange. We medicilon extend the congratulations and best wishes.
Medicilon has joined hands with in multiple pharmaceutical development projects in recent years, including external preclinical pharmacokineticstudies and safety evaluation of the androgen receptor antagonist Frestatin (KX-826) and related trials of other drug compounds. The PK and safety evaluation tests of KX-826 completed by Medicilon supports both FDA and NMPA IND filing. In addition, the drug safety evaluation of KX-826 is carried out using mini-pigs as the test species, supporting all stages from preclinical to phases I, II and III clinical trials.
Relevant
news
marketing@medicilon.com
ABOUT
